Louis W. Sullivan's Insider Trades & SAST Disclosures
Louis W. Sullivan's most recent trade in Emergent Biosolutions Inc was a trade of 34,403 Common Stock done . Disclosure was reported to the exchange on April 30, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Louis W. Sullivan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Emergent Biosolutions Inc | W. Sullivan Louis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 34,403 | 139,098 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | W. Louis Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 15,824 | 41,572 | - | - | Stock Option (Right to Buy) | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2024 | 15,000 | 0 | - | - | Stock Options | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share. | 18 Dec 2024 | 15,000 | 31,260 (0%) | 0% | 175.4 | 2,631,450 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 375.03 per share. | 18 Dec 2024 | 2,700 | 7,295 (0%) | 0% | 375.0 | 1,012,581 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 374.14 per share. | 18 Dec 2024 | 2,451 | 20,580 (0%) | 0% | 374.1 | 917,008 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 375.00 per share. | 18 Dec 2024 | 2,200 | 18,380 (0%) | 0% | 375.0 | 825,007 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 369.32 per share. | 18 Dec 2024 | 2,100 | 26,132 (0%) | 0% | 369.3 | 775,563 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 374.17 per share. | 18 Dec 2024 | 1,962 | 9,995 (0%) | 0% | 374.2 | 734,115 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 370.02 per share. | 18 Dec 2024 | 1,926 | 13,582 (0%) | 0% | 370.0 | 712,649 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Dec 2024 | 1,851 | 3,200 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 373.06 per share. | 18 Dec 2024 | 1,525 | 11,957 (0%) | 0% | 373.1 | 568,914 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 373.12 per share. | 18 Dec 2024 | 1,501 | 23,231 (0%) | 0% | 373.1 | 560,048 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 370.30 per share. | 18 Dec 2024 | 1,400 | 24,732 (0%) | 0% | 370.3 | 518,413 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 368.50 per share. | 18 Dec 2024 | 1,307 | 28,232 (0%) | 0% | 368.5 | 481,632 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 366.11 per share. | 18 Dec 2024 | 1,121 | 30,139 (0%) | 0% | 366.1 | 410,407 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 379.67 per share. | 18 Dec 2024 | 944 | 5,951 (0%) | 0% | 379.7 | 358,412 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 381.37 per share. | 18 Dec 2024 | 800 | 5,151 (0%) | 0% | 381.4 | 305,099 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 368.67 per share. | 18 Dec 2024 | 752 | 15,508 (0%) | 0% | 368.7 | 277,238 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 380.12 per share. | 18 Dec 2024 | 700 | 16,980 (0%) | 0% | 380.1 | 266,084 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 381.41 per share. | 18 Dec 2024 | 620 | 16,360 (0%) | 0% | 381.4 | 236,475 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 366.97 per share. | 18 Dec 2024 | 600 | 29,539 (0%) | 0% | 367.0 | 220,184 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 374.46 per share. | 18 Dec 2024 | 500 | 17,880 (0%) | 0% | 374.5 | 187,228 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 377.46 per share. | 18 Dec 2024 | 400 | 6,895 (0%) | 0% | 377.5 | 150,984 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 379.30 per share. | 18 Dec 2024 | 200 | 17,680 (0%) | 0% | 379.3 | 75,860 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 371.24 per share. | 18 Dec 2024 | 200 | 23,031 (0%) | 0% | 371.2 | 74,249 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 382.25 per share. | 18 Dec 2024 | 100 | 5,051 (0%) | 0% | 382.3 | 38,225 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 370.78 per share. | 18 Dec 2024 | 100 | 13,482 (0%) | 0% | 370.8 | 37,078 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 382.63 per share. | 18 Dec 2024 | 100 | 16,260 (0%) | 0% | 382.6 | 38,263 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 1,440 | 1,440 | - | - | Stock Options | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 590 | 590 | - | - | Restricted Stock Unit | |
| Emergent Biosolutions Inc | Louis W. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 25,748 | 25,748 | - | - | Stock Option (Right to Buy) | |
| Emergent Biosolutions Inc | Louis W. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 17,430 | 104,695 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 119.76 per share. | 03 May 2024 | 5,160 | 18,220 (0%) | 0% | 119.8 | 617,962 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 5,160 | 0 | - | - | Stock Options | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 259.12 per share. | 03 May 2024 | 2,979 | 13,060 (0%) | 0% | 259.1 | 771,918 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 257.39 per share. | 03 May 2024 | 2,181 | 16,039 (0%) | 0% | 257.4 | 561,366 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2023 | 4,560 | 4,560 | - | - | Stock Options | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 880 | 13,060 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 880 | 0 | - | - | Restricted Stock Unit | |
| Emergent Biosolutions Inc | Louis W. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 33,847 | 87,265 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 245.10 per share. | 01 Mar 2023 | 700 | 12,180 (0%) | 0% | 245.1 | 171,570 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 132.30 per share. | 01 Mar 2023 | 700 | 12,880 (0%) | 0% | 132.3 | 92,610 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 700 | 0 | - | - | Stock Options | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 261.33 per share. | 01 Feb 2023 | 700 | 12,180 (0%) | 0% | 261.3 | 182,931 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 132.30 per share. | 01 Feb 2023 | 700 | 12,880 (0%) | 0% | 132.3 | 92,610 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 700 | 700 | - | - | Stock Options | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 700 | 1,400 | - | - | Stock Options | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 132.30 per share. | 03 Jan 2023 | 700 | 12,880 (0%) | 0% | 132.3 | 92,610 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 276.26 per share. | 03 Jan 2023 | 700 | 12,180 (0%) | 0% | 276.3 | 193,382 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 700 | 2,100 | - | - | Stock Options | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 279.89 per share. | 01 Dec 2022 | 700 | 12,180 (0%) | 0% | 279.9 | 195,923 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 132.30 per share. | 01 Dec 2022 | 700 | 12,880 (0%) | 0% | 132.3 | 92,610 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 132.30 per share. | 01 Nov 2022 | 700 | 12,880 (0%) | 0% | 132.3 | 92,610 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 700 | 2,800 | - | - | Stock Options | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 230.28 per share. | 01 Nov 2022 | 700 | 12,180 (0%) | 0% | 230.3 | 161,196 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 132.30 per share. | 03 Oct 2022 | 710 | 12,890 (0%) | 0% | 132.3 | 93,933 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 710 | 3,500 | - | - | Stock Options | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 211.56 per share. | 03 Oct 2022 | 710 | 12,180 (0%) | 0% | 211.6 | 150,208 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 225.98 per share. | 02 Sep 2022 | 4,910 | 12,180 (0%) | 0% | 226.0 | 1,109,550 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 4,910 | 0 | - | - | Stock Options | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.80 per share. | 02 Sep 2022 | 4,910 | 17,090 (0%) | 0% | 101.8 | 499,838 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2022 | 1,080 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jul 2022 | 1,080 | 12,180 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Louis W. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 8,446 | 53,418 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2022 | 6,310 | 0 | - | - | Stock Options | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 76.36 per share. | 26 May 2022 | 6,310 | 17,410 (0%) | 0% | 76.4 | 481,832 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 224.38 per share. | 26 May 2022 | 1,766 | 13,945 (0%) | 0% | 224.4 | 396,250 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 223.37 per share. | 26 May 2022 | 1,699 | 15,711 (0%) | 0% | 223.4 | 379,506 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 226.04 per share. | 26 May 2022 | 1,500 | 12,445 (0%) | 0% | 226.0 | 339,063 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 226.74 per share. | 26 May 2022 | 1,345 | 11,100 (0%) | 0% | 226.7 | 304,963 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2021 | 3,230 | 3,230 | - | - | Stock Options | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2021 | 1,080 | 1,080 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2021 | 1,680 | 11,100 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2021 | 1,680 | 0 | - | - | Restricted Stock Units | |
| Emergent Biosolutions Inc | Louis W. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 5,027 | 44,972 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale or transfer of securities back to the company at price $ 194.30 per share. | 11 May 2021 | 15,000 | 9,420 (0%) | 0% | 194.3 | 2,914,500 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 11 May 2021 | 15,000 | 24,420 (0%) | 0% | 88.0 | 1,320,450 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 11 May 2021 | 15,000 | 24,420 (0%) | 0% | 63.9 | 958,500 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Sale or transfer of securities back to the company at price $ 194.30 per share. | 11 May 2021 | 15,000 | 9,420 (0%) | 0% | 194.3 | 2,914,500 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2021 | 15,000 | 0 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2021 | 15,000 | 0 | - | - | Share Tracking Award | |
| Emergent Biosolutions Inc | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 10,305 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.64 per share. | 10 May 2021 | 10,305 | 43,063 (0%) | 0% | 18.6 | 192,085 | Common Stock |
| Emergent Biosolutions Inc | Louis W. Sullivan | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.62 per share. | 10 May 2021 | 3,118 | 39,945 (0%) | 0% | 61.6 | 192,131 | Common Stock |
| Emergent Biosolutions Inc | Louis W. Sullivan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Sep 2020 | 10,004 | 32,758 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 111.22 per share. | 02 Sep 2020 | 20,525 | 42,762 (0%) | 0% | 111.2 | 2,282,702 | Common Stock |
| Emergent Biosolutions Inc | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2020 | 7,893 | 15,786 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Louis W. Sullivan | Director | Sale of securities on an exchange or to another person at price $ 111.23 per share. | 02 Sep 2020 | 7,893 | 42,762 (0%) | 0% | 111.2 | 877,904 | Common Stock |
| Emergent Biosolutions Inc | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.08 per share. | 02 Sep 2020 | 7,893 | 50,655 (0%) | 0% | 20.1 | 158,491 | Common Stock |
| United Therapeutics Corp | Louis W. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2020 | 5,160 | 5,160 | - | - | Stock Options | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2020 | 2,300 | 9,420 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Louis W. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2020 | 1,680 | 1,680 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges